Continued Elevation of Plasma IL-4 and IL-17 Predicts the Progression from VMC to DCM

Table 3

Prediction of incident DCM in patients with VMC (RR 95% CI).

	AUC (95% CI)
Age (yrs)	0.7961 (0.7526-0.8395)^†
Gender	0.5767 (0.5290-0.6244)
LVEF (%)	0.9092 (0.8822-0.9362)^†
UCG LV	0.9075 (0.8689-0.9461)
Ln(IL-4)	0.8566 (0.8057-0.9075)^†
Ln(IL-17)	0.7682 (0.7223-0.8141)
Basic model (without cytokine, age+gender+LVEF)	0.9155 (0.8769-0.9540)
Basic model+ln(IL-4)+ln(IL-17)	0.9344 (0.8948-0.9741)^†

^†. .